학술논문
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma
Document Type
Artikel
Author
Source
Cancer medicine. 12(22):20736-20744
Subject
Language
English
English
English
ISSN
2045-7634